The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA
Abstract
PURPOSE: Our understanding of the natural history of renal cell carcinoma, the role of nephrectomy, the benefits of immunotherapy and the possibilities of new technologies are evolving and being integrated with advances in classification and staging. We reviewed the relevant literature to clarify these pertinent questions and provide a current review of the changes in the epidemiology, treatment and prognosis of patients with renal cell carcinoma. MATERIALS AND METHODS: We comprehensively reviewed the peer reviewed literature on the current management of and results of treatment for renal cell carcinoma. RESULTS: The incidence of and mortality from renal cell carcinoma have continuously increased during the last 50 years. Despite this increase in the number of new patients and consequently the number of deaths yearly the percent of those surviving for 5 years has notably improved. Factors related to improved survival include advances in renal imaging, earlier diagnosis, improved staging, better understanding of prognostic indicators, refinement in surgical technique and the introduction of immunotherapy approaches for advanced disease. CONCLUSIONS: Currently patients with localized and metastatic renal cell carcinoma have had improvements in outlook and the therapeutic options available have expanded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kugler, A., Stuhler, G., Walden, P., Zöller, G., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Müller, C. A., Becker, V., et al. (2000) · Nature Medicine · doi:10.1038/73193 · Cited by 639
RetractedSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,774
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Walsh, M. P. C. (1986) · Cited by 3,471
Prognostic significance of morphologic parameters in renal cell carcinoma
Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198210000-00007 · Cited by 2,724
Beahrs, O. H., & Henson, D. E. (1992) · Medical Entomology and Zoology · Cited by 2,460
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma
Motzer, R. J., Mazumdar, M., Bacik, J., Berg, W., Amsterdam, A., & Ferrara, J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2530 · Cited by 1,801
Rising Incidence of Renal Cell Cancer in the United States
Chow, W.-H. (1999) · JAMA · doi:10.1001/jama.281.17.1628 · Cited by 1,586
The Results of Radical Nephrectomy for Renal Cell Carcinoma
Robson, C. J., Churchill, B. M., & Anderson, W. (1969) · Journal of Urology · doi:10.1016/s0022-5347(17)62331-0 · Cited by 1,283
The Results of Radical Nephrectomy for Renal Cell Carcinoma
Robson, C. J., Churchill, B. M., & Anderson, W. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.095 · Cited by 1,160
Childs, R., Chernoff, A., Contentin, N., Bahceci, E., Schrump, D., Leitman, S., Read, E. J., Tisdale, J., Dunbar, C., Linehan, W. M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009143431101 · Cited by 998
Classification of renal cell carcinoma: Workgroup No. 1
St�rkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., Darson, M., Delahunt, B., & Iczkowski, K. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<987::aid-cncr24>3.0.co;2-r · Cited by 864
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Zisman, A., Pantuck, A. J., Dorey, F., Said, J. W., Shvarts, O., Quintana, D., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1649 · Cited by 729
Self-citationHistopathology and Classification of Renal Cell Tumors (Adenomas, Oncocytomas and Carcinomas)
Thoenes, W., Störkel, S., & Rumpelt, H. J. (1986) · Pathology - Research and Practice · doi:10.1016/s0344-0338(86)80001-2 · Cited by 664
SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT
LEE, C. T., KATZ, J., SHI, W., THALER, H. T., REUTER, V. E., & RUSSO, P. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67793-2 · Cited by 638
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
MOTZER, R. J., & RUSSO, P. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67889-5 · Cited by 603
Renal Medullary Carcinoma The Seventh Sickle Cell Nephropathy
Davis, C. J., Mostofi, F. K., & Sesterhenn, I. A. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199501000-00001 · Cited by 599
HAFEZ, K. S., FERGANY, A. F., & NOVICK, A. C. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68071-8 · Cited by 598
Cancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Renal Cell Carcinoma: Long-Term Survival and Late Recurrence
McNichols, D. W., Segura, J. W., & DeWeerd, J. H. (1981) · Journal of Urology · doi:10.1016/s0022-5347(17)54359-1 · Cited by 495
Luciani, L. G., Cestari, R., & Tallarigo, C. (2000) · Urology · doi:10.1016/s0090-4295(00)00534-3 · Cited by 452
Steiner, M. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62878-7 · Cited by 424
Moch, H., Schraml, P., Bubendorf, L., Mirlacher, M., Kononen, J., Gasser, T., Mihatsch, M. J., Kallioniemi, O. P., & Sauter, G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65349-7 · Cited by 391
Renal cell carcinoma: earlier discovery and increased detection.
Smith, S. J., Bosniak, M. A., Megibow, A. J., Hulnick, D. H., Horii, S. C., & Raghavendra, B. N. (1989) · Radiology · doi:10.1148/radiology.170.3.2644658 · Cited by 355
Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma.
Elson, P. J., Witte, R. S., & Trump, D. L. (1988) · PubMed · Cited by 340
Amin, M. B., Corless, C. L., Renshaw, A. A., Tickoo, S. K., Kubus, J., & Schultz, D. S. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199706000-00001 · Cited by 335
RENAL CELL CARCINOMA: PROGNOSTIC SIGNIFICANCE OF INCIDENTALLY DETECTED TUMORS
TSUI, K.-H., SHVARTS, O., SMITH, R. B., FIGLIN, R., de KERNION, J. B., & BELLDEGRUN, A. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67892-5 · Cited by 332
Self-citationNephron Sparing Surgery for Renal Cell Carcinoma
Licht, M. R., & Novick, A. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35982-7 · Cited by 330
Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
Bukowski, R. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1198::aid-cncr3>3.0.co;2-h · Cited by 325
Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.
Quesada, J. R., Rios, A., Swanson, D., Trown, P., & Gutterman, J. U. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.11.1522 · Cited by 272
Chromophobe Cell Renal Carcinoma: Clinicopathological Features of 50 Cases
Crotty, T. B., Farrow, G. M., & Lieber, M. M. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)66944-1 · Cited by 268
RENAL CELL CARCINOMA: MANAGEMENT OF ADVANCED DISEASE
FIGLIN, R. A. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)61897-4 · Cited by 266
Motzer, R. J., Murphy, B. A., Bacik, J., Schwartz, L. H., Nanus, D. M., Mariani, T., Loehrer, P., Wilding, G., Fairclough, D. L., Cella, D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2972 · Cited by 264
Figlin, R. A., Thompson, J. A., Bukowski, R. M., Vogelzang, N. J., Novick, A. C., Lange, P., Steinberg, G. D., & Belldegrun, A. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2521 · Cited by 212
Self-citationCYTOTOXIC CHEMOTHERAPY FOR ADVANCED RENAL CELL CARCINOMA
Yagoda, A., Petrylak, D., & Thompson, S. (1993) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00489-4 · Cited by 207
Farkas, A., Schneider, D., Perrotti, M., Cummings, K. B., & Ward, W. S. (1998) · Urology · doi:10.1016/s0090-4295(98)00242-8 · Cited by 202
Chromophobe Cell Carcinoma of the Kidney
Akhtar, M., Kardar, H., Linjawi, T., & McClintock, J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199511000-00004 · Cited by 173
The national cancer data base: Report on kidney cancers
Marshall, F. F., Stewart, A. K., & Menck, H. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971201)80:11<2167::aid-cncr18>3.0.co;2-x · Cited by 172
TSUI, K.-H., SHVARTS, O., BARBARIC, Z., FIGLIN, R., de KERNION, J. B., & BELLDEGRUN, A. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67895-0 · Cited by 168
Self-citationFiglin, R. A., Pierce, W. C., Kaboo, R., Tso, C. L., Moldawer, N., Gitlitz, B., deKernion, J., & Belldegrun, A. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64304-0 · Cited by 160
Self-citationZisman, A., Pantuck, A. J., Chao, D. H., DOREY, F. J., SAID, J. W., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66075-2 · Cited by 151
Self-citationThe Incidence of Benign Renal Nodules (A Clinicopathologic Study)
Xipell, J. M. (1971) · The Journal of Urology · doi:10.1016/s0022-5347(17)61327-2 · Cited by 144
Evaluation of the New Tumor, Nodes and Metastases Classification of Renal Cell Carcinoma
Hermanek, P., & Schrott, K. M. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39420-x · Cited by 142
Dunn, M. D., Portis, A. J., Elbahnasy, A. M., Shalhav, A. L., Rothstein, M., McDougall, E. M., & Clayman, R. V. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70021-7 · Cited by 120
Scott, C., Nelson, J. S., Farnan, N. C., Curran, W. J., Murray, K. J., Fischbach, A. J., Gaspar, L. E., & Nelson, D. F. (1995) · Cancer · doi:10.1002/1097-0142(19950715)76:2<296::aid-cncr2820760221>3.0.co;2-l · Cited by 84
Diagnosis of Renal Cancer by Molecular Urinalysis
Eisenberger, C. F., Schoenberg, M., Enger, C. L., HORTOPAN, S. C., Shah, S., Chow, N. ‐., Marshall, F. F., & Sidransky, D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2028 · Cited by 74
p53, bcl-2, and Bax Expression in Renal Cell Carcinoma
Vasavada, S. P., Novick, A. C., & Williams, B. R. G. (1998) · Urology · doi:10.1016/s0090-4295(98)00132-0 · Cited by 69
Citterio, G., Bertuzzi, A. F., Tresoldi, M., Galli, L., Lucca, G. D., Scaglietti, U., & Rugarli, C. (1997) · European Urology · doi:10.1159/000474469 · Cited by 68
Dutcher, J. P., Atkins, M. B., Fisher, R. I., Weiss, G. R., Margolin, K. A., Aronson, F. R., Sosman, J. A., Lotze, M. T., Gordon, M. S., Logan, T. F., et al. (1997) · PubMed · Cited by 67
Expression of Bcl-2, p53 Oncoprotein, and Proliferating Cell Nuclear Antigen in Renal Cell Carcinoma
Sejima, T., & Miyagawa, I. (1999) · European Urology · doi:10.1159/000019855 · Cited by 57
New Insights into the Structure and Function of the Thyroid Hormone Receptor
Cheng, S.-Y. (1995) · Journal of Biomedical Science · doi:10.1007/bf02253060 · Cited by 55
Cited by
Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W., & Charbonneau, C. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.12.001 · Cited by 974
Leibovich, B. C., Blute, M. L., Cheville, J. C., Lohse, C. M., Frank, I., Kwon, E. D., Weaver, A. L., Parker, A. S., & Zincke, H. (2003) · Cancer · doi:10.1002/cncr.11234 · Cited by 837
Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Krejci, K. G., Lobo, J. R., Sengupta, S., Chen, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406351101 · Cited by 776
Zisman, A., Pantuck, A. J., Wieder, J., Chao, D. H., Dorey, F., Said, J. W., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.111 · Cited by 675
Self-citationThe natural history of incidentally detected small renal masses
Volpe, A., Panzarella, T., Rendon, R. A., Haider, M. A., Kondylis, F. I., & Jewett, M. A. S. (2004) · Cancer · doi:10.1002/cncr.20025 · Cited by 526
Metadata
- Authors
- PANTUCK, A. J., ZISMAN, A., & BELLDEGRUN, A. S.
- Venue
- Journal of Urology
- Published
- 2001-11
- Volume
- 166
- Issue
- 5
- Pages
- 1611-1623
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2144390074
- Cited by
- 882
- References
- 53
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.